Merger & Acquisition Trends in the Healthcare Industry
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/merger-acquisition-trends-in-the-healthcare-industry",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5633975554,
"post_summary": "<p>Global M&A deals across all industries exceeded $1.0 trillion during the second quarter of 2014, the highest level since 2007, according to Thompson Reuters. Private equity groups and corporations, sitting on stockpiles of cash coupled with the ability to borrow at record low rates, are helping drive the acquisition spree. The healthcare industry appears to be riding the coattails of the overall market activity. Through the first half of 2014 the healthcare sectors tracked by the <em>PCE Industry Update – Healthcare</em> show that 729 M&A transaction deals were announced or closed compared to only 631 in the same period in 2013.</p> \n",
"title": "Merger & Acquisition Trends in the Healthcare Industry",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
}A Prescription for M&A – Compound Pharmacies Face Change
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/a-prescription-for-ma-compound-pharmacies-face-change",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634047806,
"post_summary": "<p>The compounding pharmacy industry is ripe for consolidation and many anticipate a pickup in M&A activity. As compounding pharmacist head to Washington, DC to attend the industry insiders “IACP’s 20th Compounders on Capitol Hill 2014” summit later this month, it is worthwhile to provide insight on this subsector.</p> \n",
"title": "A Prescription for M&A – Compound Pharmacies Face Change",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
}Props
{
"defaultContent": {
"nextPage": "Next page",
"previousPage": "Previous page"
},
"defaultRules": {
"lockHeadingTextField": true
},
"dataQueryResult": {},
"fieldValues": {
"defaultContent": {
"nextPage": "Next page",
"previousPage": "Previous page"
},
"defaultRules": {
"lockHeadingTextField": true
}
},
"hublParameters": {
"field_types": {
"defaultContent": "group",
"defaultRules": "group"
},
"is_widget_block": true,
"module_id": 209876701002,
"org_tag": "module_block",
"parent_widget_container": "main",
"path": "@projects/react-theme-huzaifa/theme/components/modules/BlogListing",
"smart_type": "NOT_SMART",
"widget_type": "module",
"wrap_field_tag": "div"
},
"hublData": {
"blogPostIds": [
5633975554,
5634047806
],
"blogPosts": [
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/merger-acquisition-trends-in-the-healthcare-industry",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5633975554,
"post_summary": "<p>Global M&A deals across all industries exceeded $1.0 trillion during the second quarter of 2014, the highest level since 2007, according to Thompson Reuters. Private equity groups and corporations, sitting on stockpiles of cash coupled with the ability to borrow at record low rates, are helping drive the acquisition spree. The healthcare industry appears to be riding the coattails of the overall market activity. Through the first half of 2014 the healthcare sectors tracked by the <em>PCE Industry Update – Healthcare</em> show that 729 M&A transaction deals were announced or closed compared to only 631 in the same period in 2013.</p> \n",
"title": "Merger & Acquisition Trends in the Healthcare Industry",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
},
{
"absoluteUrl": "http://computan-2661279.hs-sites.com/test-blog/a-prescription-for-ma-compound-pharmacies-face-change",
"featuredImage": "",
"featuredImageAltText": "",
"featuredImageHeight": 0,
"featuredImageWidth": 0,
"id": 5634047806,
"post_summary": "<p>The compounding pharmacy industry is ripe for consolidation and many anticipate a pickup in M&A activity. As compounding pharmacist head to Washington, DC to attend the industry insiders “IACP’s 20th Compounders on Capitol Hill 2014” summit later this month, it is worthwhile to provide insight on this subsector.</p> \n",
"title": "A Prescription for M&A – Compound Pharmacies Face Change",
"topicNames": [
"Articles",
"healthcare",
"Hide Date",
"M&A"
]
}
],
"currentPageNumber": 2,
"nextPageNumber": 3,
"previousPageNumber": null,
"totalPageCount": 9,
"use_featured_image_in_summary": true
},
"experimentalHublData": null,
"moduleName": "main-module-2",
"supplementalFieldValues": {
"defaultContent": {
"nextPage": {},
"previousPage": {}
},
"defaultRules": {
"lockHeadingTextField": {}
}
}
}